Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 4 of 13 for:    18539917 [PUBMED-IDS]

Effectiveness & Tolerability of Novel, Initial Triple Combination Therapy vs Conventional Therapy in Type 2 Diabetes

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02946632
Recruitment Status : Not yet recruiting
First Posted : October 27, 2016
Last Update Posted : October 27, 2016
Sponsor:
Collaborator:
AstraZeneca
Information provided by (Responsible Party):
Sin Gon Kim, Korea University Anam Hospital

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Not yet recruiting
Estimated Primary Completion Date : December 2019
Estimated Study Completion Date : December 2019
Publications of Results:

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):